Lv11
50 积分 2025-06-23 加入
Primary Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs): Contexts and Comparisons in EGFR-Mutated Lung Cancer
38分钟前
待确认
Molecular and therapeutic landscape of non-clear cell renal carcinoma
2小时前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
20天前
已完结
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial
1个月前
已关闭
Testicular cancer
1个月前
已关闭
Testicular Germ Cell Tumors
1个月前
已完结
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2025 edition)]
2个月前
已完结
Non-small cell lung cancer with EGFR exon 20 insertion mutation: a systematic literature review and meta-analysis of patient outcomes
2个月前
已完结
The endosomal-lysosomal system in ADC design and cancer therapy
5个月前
已完结
Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage Small Cell Lung Cancer: Results From TROPiCS-03
5个月前
已完结
皖公网安备34019202002308
